2-(p-Tolyloxy)ethyl acetate
Common Name: |
2-(p-Tolyloxy)ethyl acetate |
IUPAC Name: |
2-(4-methylphenoxy)ethyl acetate |
Molecular Formula: |
C11H14O3 |
SMILES: |
CC1=CC=C(C=C1)OCCOC(=O)C |
Inchi: |
1S/C11H14O3/c1-9-3-5-11(6-4-9)14-8-7-13-10(2)12/h3-6H,7-8H2,1-2H3 |
Inchi Key: |
ZJMLZGKLUMJGSL-UHFFFAOYSA-N |
Cas No: |
6807-11-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
194.23 |
Mass (g/mol) |
194.094 |
Molar Refractivity |
53.61 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
266.00 to 267.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.008 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.36 |
LogP |
1.937 |
iLOGP |
2.66 |
XLOGP3 |
2.15 |
WLOGP |
1.94 |
MLOGP |
1.96 |
ESOL Log S |
-2.39 |
ESOL Solubility (mg/ml) |
0.799 |
ESOL Solubility (mol/l) |
0.004 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.53 |
Ali Solubility (mg/ml) |
0.58 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.41 |
Silicos-IT Solubility (mg/ml) |
0.07 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.96 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.71 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.513 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |